Seeking people with mild Alzheimer’s disease for innovative clinical trial

Tweet about this on TwitterShare on FacebookShare on Google+Share on LinkedInEmail this to someonePrint this page

This clinical trial is testing whether a new drug, called Azilarigon, is effective in the treatment of Alzheimer’s disease compared to a placebo. This medication is to be taken in addition to current Alzheimer’s disease medication(s).

The study lasts for 23 months and includes 9 visits to the Warneford Hospital in Oxford. Volunteers need to be willing to undertake a range of memory tests, blood tests and physical health monitoring, and undergo two brain scans in a specially designated imaging unit.

We ask that participants have a study partner, for example a family member, carer and friend who has regular contact with them to accompany them to visits.

Patients will be eligible to participate in the study if they fulfil the inclusion criteria.

Reimbursement

Patient travel expenses will be reimbursed for study visits, and a meal voucher supplied.

Date required

Ongoing

Organisation

Oxford Health NHS Foundation Trust

Contact

Jemima Hume
Research Nurse
01865 902694

Clinical Trial Registration Details

https://steadfastalzheimers.com/

IRAS: 205067